On Oct. 28, the US Department of Health and Human Services served notice that it plans to repeal a controversial Trump rule.
Subscribe today for full access
to all of these articles.
From - Lab Compliance Advisor
While FDA oversight over new diagnostic tests is perfectly acceptable, what is objectionable is the…